CRISPR Therapeutics is seeking a hands-on Research Associate II to support oligonucleotide synthesis, purification, and conjugation for gene-editing and targeted-delivery programs. The role involves running solid-phase oligonucleotide synthesis on automated platforms, purifying and characterizing crude material to research-grade specifications, and preparing small molecule–oligonucleotide and antibody–oligonucleotide conjugates. This is a bench-intensive position in a fast-moving discovery chemistry group. Working under senior scientists, the associate will execute defined experimental plans, progressively take ownership of syntheses, purification campaigns, and conjugation reactions, and deliver well-documented material on time to in vitro and in vivo study teams. CRISPR Therapeutics is a biopharmaceutical company developing gene-based medicines for serious human diseases. Its pipeline spans hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine, and rare diseases. The company also develops SyNTase™, a gene-editing platform, and has strategic collaborations including with Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with U.S. R&D operations in Boston and San Francisco. The role is fully on-site. The listed base pay range is $85,000 to $92,000, plus bonus, equity, and benefits.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level